Philips Archives - Page 16 of 19 - Medical Design Sourcing

Philips and Disney want to make MRIs easier for children: Here’s how

Image from Philips

Royal Philips (NYSE:PHG) announced today that it is teaming up with Disney to test the effects of custom-made animation to create a relaxing atmosphere for patients.

Amsterdam-based Philips will collaborate with The Walt Disney Company EMEA to see how the animation, including specially-made Disney stories within Philips’ Ambient Experience, creates a relaxing atmosphere to improve both the patient and clinical experience during pediatric MRI procedures, according to a news release.

Get the full story at our sister site, Medical Design & Outsourcing.

Philips and Disney want to make MRIs easier for children: Here’s how

Image from Philips

Royal Philips (NYSE:PHG) announced today that it is teaming up with Disney to test the effects of custom-made animation to create a relaxing atmosphere for patients.

Amsterdam-based Philips will collaborate with The Walt Disney Company EMEA to see how the animation, including specially-made Disney stories within Philips’ Ambient Experience, creates a relaxing atmosphere to improve both the patient and clinical experience during pediatric MRI procedures, according to a news release.

Disney’s animation features characters like Mickey Mouse, Ariel (The Little Mermaid), Marvel’s Avengers, Yoda (Star Wars) and more. Patients will be allowed to select DIsney content featuring their favorite character to give a sense of familiarity, control and comfort.

The goal of the research pilot is to help alleviate childrens’ anxiety and allow the staff to create bonds…

Philips, DiA partner on AI-based applications for ultrasound

Philips enhances ultrasound with AI-based image quantification [Image courtesy of Philips]Philips (NYSE: PHG, AEX: PHIA) announced today that it has formed a strategic partnership with DiA Imaging Analysis to incorporate DiA’s AI library of automated solutions with Philips ultrasound.

Be’er Sheva, Israel–based DiA’s AI-enabled 2D ultrasound applications have FDA clearance and a CE Mark. The applications are geared toward reducing variability and increasing the efficiency and accuracy of ultrasound analysis.

“Through our strategic partnership with DiA Imaging Analysis, we can deliver unprecedented diagnostic confidence and operational efficiency to point-of-care ultrasound imaging, as well as widen access to high quality and timely care both inside and outside of hospitals,” said Kees Wesdorp, chief business leader of Precision Diagnosis at Philips.

DiA Hila Goldman Aslan described Philips’ ultrasound devices as an “ideal …

MedTech 100 roundup: Rise to new heights continues

The medtech industry hit another high as 2021 continues to bring strong performances out of some of the biggest companies around.

MassDevice‘s MedTech 100 index ended the week (Feb. 12) at 110.63 points, marking a 2.2% rise from the 108.23-point mark set at the end of the previous week (Feb. 5).

The final mark for the week sets an all-time best for the index, which had previously reached 106.81 points on Jan. 8, then 107.4 points on Jan. 20 before besting itself again with last week’s finish. The rise has been considerably impressive given that the index had never reached even the 100-point mark before November 2020.

Medtech’s latest rise means the index has risen 19.8% from the pre-COVID-19 pandemic high of 92.32, set on Feb. 19, 2020. Additionally, the industry has very much rebounded from its lowest place, a 62.13-point mark at the start of the pandemic on March 23, 2020. Since that point, the industry has jumped 78.1%.

Medtech’s performa…

DTW #45: Kamen talks 3D organs; Todd Pope returns as CEO; Joe Mulling says Medtech’s time is now

DeviceTalks Weekly, powered by MassDevice

Please lift this jam-packed episode of the DeviceTalks Weekly Podcast with your legs, not your back.

We’ll hear inspirational words from the legendary Dean Kamen who is shifting his life’s focus into medtech. Todd Pope takes the CEO seat at a new company built to tackle hospital-acquired-infections and COVID Joe Mullings of the Mullings Group explains why now is the best time to be in the Medtech industry.

Chris Newmarker, executive editor of life sciences, delivers a murderers row of #newmarkersnewsmakers with Philips, Medtronic, iRyhthm, Canary Medical and Apollo Endosurgery.

To hear Dean Kamen’s entire interview with Design World’s Paul Heney go here.

Thanks for subscribing!

DeviceTalks by MassDevice · Dean Kamen eyeing 3D organs; Todd Pope talks clean air; Joe Mullings says Medtech’s time is now

DTW #45: Kamen talks 3D organs; Todd Pope returns as CEO; Joe Mulling says Medtech’s time is now

Please lift this jam-packed episode with your legs, not your back.

We’ll hear inspirational words from the legendary Dean Kamen who is shifting his life’s focus into medtech. WellAir’s Todd Pope takes the CEO seat at a new company built to tackle hospital-acquired-infections and COVID Joe Mullings of the Mullings Group explains why now is the best time to be in the Medtech industry.

Chris Newmarker, executive editor of life sciences, delivers a murderers row of #newmarkersnewsmakers with Philips, Medtronic, iRyhthm, Canary Medical and Apollo Endosurgery.

To hear Dean Kamen’s entire interview with Design World’s Paul Heney go here.

Don’t miss a future episode! Subcribe now!

DeviceTalks by MassDevice · Dean Kamen eyeing 3D organs; Todd Pope talks clean air; Joe Mullings says Medtech’s time is now

These 5 medtech companies made it into the top 200 of Forbes’ best places to work list

Johnson & Johnson, Steris, Philips, Fujifilm Holdings and Boston Scientific were recently named among Forbes’ best large employers in America, based on feedback from their employees.

Forbes partnered with a market research firm to survey 50,000 Americans working for businesses with at least 1,000 employees. Survey participants were asked to rate their willingness to recommend their employer to friends and family and to nominate a business that wasn’t their own.

Get the full story on our sister site, Medical Design & Outsourcing.

Philips completes $2.8B BioTelemetry acquisition

Royal Philips (NYSE:PHG) announced today that it successfully completed its acquisition of all outstanding shares of BioTelemetry (NSDQ:BEAT).

Amsterdam-based Philips announced in December 2020 that it agreed to acquire the shares of BioTelemetry at a per-share price of $72, totaling approximately $2.8 billion. At 12 a.m. ET today, the offer expired as scheduled and was not extended as Philips expects to complete the acquisition later today through a merger, according to a news release.

As of the expiration of the offer, a total of more than 27 million shares (representing almost 79% of BioTelemetry’s outstanding shares) had been tendered into and not validly withdrawn. Additionally, the companies were advised that another 1.57 million shares were tendered by notice of guaranteed delivery. All shares that were validly tendered and not properly withdrawn were accepted for payment and Philips will pay for all such tendered shares in accordance with the term…

DTW Podcast: Zimmer Biomet slims, Corza Medical grows in pursuit of grabbing market share

In this week’s DeviceTalks Weekly Podcast, Rich Newitter, managing director at SVB Leerink, says Zimmer Biomet’s decision to spin out its spinal and dental business will accelerate its already impressive market share grab in its core orthopedics industry.

Dewitter says CEO Bryan Hanson brings a tried-and-true diversification model used by companies like his former employer, Covidien. The spinout of the spinal and dental businesses into a NewCo will allows the company to focus more resources on selling knee and hip implants as well as building out an impressive robotics franchise and a potentially sector-leading line of digital tools and sensors.

“Zimmer has effectively gone from a share loser for almost a decade leading up to when Bryan Hanson took over to a share-taking position,” he said in an interview with Chris Newmarker, executive editor of life sciences. “This most recent quarter, their share gains have widened quite dramatically.”

In …

Philips introduces Medical Tablet for remote patient monitoring

[Philips Medical Tablet images courtesy of Philips]Royal Philips (NYSE:PHG) recently announced the launch of its Medical Tablet in North America, Europe and Japan.

The Philips Medical Tablet is meant to provide remote access to patient data. The goal is to allow health providers to improve workflows and better manage increases in patient volume. A fully portable setup is possible for the remote monitoring kit— an important feature during the present COVID-19 pandemic as well as future emergencies. Plus, the Medical Tablet is not linked to a central monitoring station, so it can communicate through a WiFi connection.

“As clinicians work to navigate increased workloads, safety concerns, and transitions to remote care settings, they require solutions that map to these increasingly challenging circumstances,” said Peter Ziese, GM of Monitoring Analytics at Philips.

“The Philips Medical Tablet with IntelliVue XDS software gives clinicians critical patient data l…

MedTech 100 roundup: Another peak for the industry

Medtech has been on the rise in 2021 and the past week saw that trend continue, as the industry hit yet another all-time best mark.

MassDevice‘s MedTech 100 index reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 set on Feb. 19, 2020, and a 72.9% overall leap from the lowest point of 62.13 set on March 23, 2020.

Here are some of the best-performing medtech stocks from 2020.

The high point could not be sustained, but the industry stayed strong, finishing at 106.4 to end the week on Jan. 22. Medtech’s finish to last week was enough to top the previous seven days, coming in 0.6% ahead of the 105.8-point mark set on Jan. 15.

While medtech saw slight growth from the previous week, one of the overall markets saw a larger jump, with the S&P 500 Index rising 1.9%. The Dow Jones Industrial Average fared identically to medtech, rising 0.6%.

DTW Podcast Ep. 42 – How the pandemic has accelerated, slowed medtech innovation

The pandemic has accelerated innovation in many ways but the physical pressures on entrepreneurs, innovators and engineers is very real.

In this episode of the DeviceTalks Weekly Podcast, a panel representing early-stage and tech transfer efforts explain how they’re helping individuals and young companies work through the unique challenges of the time, including finding capital, working with corporates, understanding opportunities in a changing healthcare market, seeing the silver linings

Guests include

Jennifer McCaney, PhD,,co-executive director, UCLA Biodesign Jackie Mejia, PhD, director, gBeta Medtech Scott Morley, director, office of economic partnerships, University of Pittsburgh

This conversation is a condensed version of our Jan. 19 DeviceTalks Tuesday. Go to DeviceTalks.com to watch the entire on-demand presentation.

Co-host Chris Newmarker, executive editor of MassDevice, also shares his top 5 stories of the week, aka, #Newmarker…